PubRank

S M Krams

Author PubWeight™ 30.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 1996 1.89
2 Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg 1998 1.53
3 MicroRNAs as immune regulators: implications for transplantation. Am J Transplant 2010 1.16
4 An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995 1.13
5 Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines. J Immunol 1997 1.12
6 Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995 1.11
7 Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995 0.99
8 Differential expression of microRNAs during allograft rejection. Am J Transplant 2012 0.98
9 Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology 2000 0.97
10 Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. Transplant Proc 1995 0.96
11 Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation 1993 0.91
12 Apoptosis and allograft rejection in the absence of CD8+ T cells. Transplantation 2001 0.90
13 Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis. Semin Liver Dis 1989 0.90
14 Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway. J Immunol 2001 0.90
15 Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 1995 0.89
16 Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis. Liver 2001 0.88
17 Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992 0.88
18 Differential patterns of circulating intercellular adhesion molecule-1 (cICAM-1) and vascular cell adhesion molecule-1 (cVCAM-1) during liver allograft rejection. Transplantation 1995 0.88
19 Characterization of allograft rejection in an experimental model of small intestinal transplantation. J Gastrointest Surg 1999 0.87
20 Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma. Am J Transplant 2009 0.85
21 Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Transplantation 1995 0.85
22 Acute liver allograft rejection in the rat. An analysis of the immune response. Transplantation 1995 0.84
23 CD30 expression identifies a functional alloreactive human T-lymphocyte subset. Transplantation 1998 0.81
24 PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas. Am J Transplant 2013 0.81
25 IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 1993 0.79
26 Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. Transplantation 1998 0.79
27 Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. Liver Transpl 2000 0.78
28 Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder. Am J Transplant 2013 0.78
29 Interleukin-12: a possible cytotoxic T-lymphocyte differentiation factor in allograft recipients. Transplant Proc 1995 0.78
30 Cytokines are involved in the rejection of small intestine allografts. Transplant Proc 1997 0.77
31 EBV B lymphoma cell lines from patients with post-transplant lymphoproliferative disease are resistant to TRAIL-induced apoptosis. Am J Transplant 2006 0.77
32 Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. Transplantation 1996 0.77
33 Involvement of Fas-Fas ligand interactions in graft rejection. Int Rev Immunol 1999 0.76
34 Acute rejection of small intestine allografts is associated with increased expression of toll-like receptors. Transplant Proc 2010 0.75
35 Circulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in pediatric liver recipients. Transplant Proc 1995 0.75
36 Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection. Transplant Proc 1993 0.75
37 Elevated biliary interleukin 5 as an indicator of liver allograft rejection. Transpl Immunol 1995 0.75
38 Characterization of cytokine expression in an animal model of acute liver allograft rejection. Transplant Proc 1995 0.75
39 Long-term nonresponsiveness to a liver allograft may be cytokine mediated. Transplant Proc 1995 0.75
40 T cell receptor usage by cytotoxic T lymphocytes against autologous human melanoma. Anticancer Res 1997 0.75
41 Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients. Transplant Proc 1995 0.75